Beta-blocker use and cardiovascular event risk in patients with heart failure with preserved ejection fraction
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beta-blocker use and cardiovascular event risk in patients with heart failure with preserved ejection fraction
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-06-18
DOI
10.1038/s41598-018-27799-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of Cardiovascular Events in Patients With Diabetes Mellitus on β-BlockersNovelty and Significance
- (2017) Tetsuro Tsujimoto et al. HYPERTENSION
- Intensive Glycemic Therapy in Patients With Type 2 Diabetes on β-Blockers
- (2016) Tetsuro Tsujimoto et al. DIABETES CARE
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Heart Failure with Preserved Ejection Fraction
- (2016) Margaret M. Redfield NEW ENGLAND JOURNAL OF MEDICINE
- The Propensity Score
- (2015) Jason S. Haukoos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effectiveness of Prior Use of Beta-Blockers for Preventing Adverse Influences of Severe Hypoglycemia in Patients With Diabetes
- (2015) Tetsuro Tsujimoto et al. MEDICINE
- Beta-blockers in heart failure with preserved ejection fraction: a meta-analysis
- (2014) Chirag Bavishi et al. HEART FAILURE REVIEWS
- Association Between Use of β-Blockers and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction
- (2014) Lars H. Lund et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Spironolactone for Heart Failure with Preserved Ejection Fraction
- (2014) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heart failure with preserved ejection fraction
- (2014) James D. Gladden et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Effects of Beta-Blockers on Heart Failure with Preserved Ejection Fraction: A Meta-Analysis
- (2014) Feng Liu et al. PLoS One
- 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2013) Clyde W. Yancy et al. CIRCULATION
- Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction
- (2012) Benjamin A. Steinberg et al. CIRCULATION
- Baseline Characteristics of Patients in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial
- (2012) Sanjiv J. Shah et al. Circulation-Heart Failure
- Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF)
- (2012) Kazuhiro Yamamoto et al. EUROPEAN JOURNAL OF HEART FAILURE
- Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction
- (2011) Akshay S. Desai et al. AMERICAN HEART JOURNAL
- Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study
- (2011) Viviane M. Conraads et al. EUROPEAN JOURNAL OF HEART FAILURE
- Métodos de puntuación de propensión para crear una distribución equilibrada de las covariables en los estudios observacionales
- (2011) Cassandra W. Pattanayak et al. REVISTA ESPANOLA DE CARDIOLOGIA
- Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction
- (2009) Dirk J. van Veldhuisen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started